Videos

Elaine Shum, MD, discusses emerging targeted therapies in EGFR-mutant non–small cell lung cancer.  



Dr. Shum on Emerging Targeted Therapies in EGFR-Mutant NSCLC 

Joshua K. Sabari, MD, discusses novel immunotherapy combinations that are under investigation in non–small cell lung cancer.

Dr. Sabari on Novel Immunotherapy Combos Under Investigation in NSCLC

Jeffrey S. Weber, MD, PhD, discusses emerging therapies in melanoma.

Dr. Weber on Emerging Therapies in Melanoma  

Podcasts

In our exclusive interview, Marc J. Braunstein, MD, PhD, provides perspective on data in the upfront and relapsed/refractory settings regarding the use of triplet and quadruplet regimens, novel agents, and cellular therapies.

Research Reflections: Braunstein Breaks Down Top ASCO 2020 Abstracts in Myeloma

Articles

Vamsidhar Velcheti, MD, discusses the current and emerging treatment options for patients with ALK- and ROS1-positive non–small cell lung cancer.

Next-Generation TKIs Continue to Impress in ALK+ and ROS1+ NSCLC

Elaine Shum, MD, discusses consulting patients with non-small cell lung cancer on the use of osimertinib.

Perlmutter Cancer Center at NYU Langone

Latest from Perlmutter Cancer Center at NYU Langone

New content coming soon, please check back later.